Camillo Mancini

1.2k citations
40 papers · 985 indexed · h-index 18

Camillo Mancini

39 papers receiving 929 citations

Peers

Camillo Mancini
Comparison fields: 5 of 95
  • Biotechnology 180
  • Immunology 274
  • Cancer Research 147
  • Molecular Biology 476
  • Oncology 164
Replace James E. Metherall with:
James E. Metherall United States
Roland Günther United States
J I Gordon United States
Shiun‐Kwei Chiou United States
Nickolay Neznanov United States
Ye V. Liu United States
Charles Lefebvre Canada
Benjamin Peng Australia
W M Lee United States
L Shi Canada
Camillo Mancini relative to James E. Metherall United States James E. Metherall's profile →
Citations per field
00.5×1.5×2.4×
James E. Metherall · 1×
Citations per year

Countries citing papers authored by Camillo Mancini

Since Specialization
Citations

This map shows the geographic impact of Camillo Mancini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camillo Mancini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camillo Mancini more than expected).

Fields of papers citing papers by Camillo Mancini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camillo Mancini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camillo Mancini. The network helps show where Camillo Mancini may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Camillo Mancini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Camillo Mancini Line = papers co-authored together Camillo Mancini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20129
3 201013
4 200961
5 200928
6 200447
7 200244
8 200223
9 200098
10 199942
11 199724
12 199526
13 199523
14 19901
15 198917
16 19891
17 19893
18 19889
19 198717
20 198110

About Camillo Mancini

Camillo Mancini is a scholar working on Immunology, Neurology and Biotechnology, having authored 40 papers that have together received 985 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (9 papers), Cancer, Hypoxia, and Metabolism (6 papers), Transgenic Plants and Applications (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (5 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Biotechnology (180 citations), Immunology (274 citations) and Cancer Research (147 citations). Camillo Mancini has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include G. Doria, Giuseppe Raschellà, Barbara Tanno, Eugenio Benvenuto, Roberta Vitali, Bruno Calabretta, Gino Doria, Vincenzo Cesi, Luciano Adorini and Kai Zhao. Their work appears in journals such as The Journal of Immunology, Clinical Cancer Research, Cell Death and Differentiation, Journal of Biological Chemistry and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026